In a surprising move, Pfizer Inc. (NYSE: PFE), a leading global pharmaceutical company, has announced it is stopping its ambitious $350 million manufacturing plant project in Everett, underscoring the volatile nature of the pharmaceutical industry and its strategic recalibrations. The decision, confirmed in a report by the Puget Sound Business Journal on Friday, marks a […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
Vancouver's Equitable Development planners will brief the Planning Commission on Oct. 13...
ByThe RegistrySeptember 29, 2026Bellevue has opened the hunt for a progressive design-builder to turn the...
ByThe RegistrySeptember 29, 2026Kemper Development pauses its $1 billion, three-tower "The Bellevue" expansion, leaving the...
ByThe RegistrySeptember 29, 2026Infill Industrial Partners paid $31.8 million for a 126,457-square-foot Renton warehouse from...
ByThe RegistrySeptember 29, 2026